Science news articles about 'oxford biomedica'

LONDON (Reuters) - Long-term tests on monkeys using Oxford BioMedica's gene therapy ProSavin suggest it can treat Parkinson's disease without causing the jerky, involuntary movements ...

... in Geneva yesterday (Thursday 23 October), Dr Richard Harrop, vice-president of clinical immunology at Oxford BioMedica, a UK-based biotechnology company – said: "Our ...